Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • News item (10)
  • Page (3)
  • Subject (2)

Publication date

Selecting an option will change the focus to the start of the list.
  • February 2026 (1)
  • May 2024 (1)
  • April 2024 (1)
  • February 2024 (1)
  • November 2023 (1)
  • November 2022 (1)
  • September 2022 (1)
  • January 2022 (1)
  • November 2020 (1)
  • June 2020 (1)
  • December 2019 (1)
  • May 2019 (1)
  • April 2019 (2)
  • July 2013 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • (-) National Immunisation Programme (14)
  • (-) Digitale zorg (1)
  • International (185)
  • COVID-19 (96)
  • International projects (64)
  • Nanotechnology and advanced materials (53)
  • Food safety (22)
  • Circular economy (20)
  • RIVM (20)
  • Soil and water (20)
  • Flu and flu vaccine (19)
  • Tobacco (17)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (17)
  • Alternatives to animal testing (15)
  • Antimicrobial resistance (15)
  • Behavioural science (15)
  • Consumer exposure to chemical substances (15)
  • Heat (15)
  • Food and Nutrition (13)
  • Rubber granulate (13)
  • Sexually transmitted infections (STIs) (13)
  • Health research for COVID-19 (12)
  • Immunisation and vaccination (11)
  • Incidents and disasters (11)
  • Infectious Disease Control (11)
  • Mpox (11)
  • Occupational Safety (11)
  • Plastics (11)
  • Cervical cancer screening programme (10)
  • ConsExpo (10)
  • One Health (10)
  • PFAS (10)
  • Tick bites (10)
  • Dutch National Food Consumption Survey (9)
  • Medical devices (9)
  • Public Health Foresight (9)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (9)
  • Zoonotic diseases (9)
  • Mental Health (8)
  • Tuberculosis (8)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (8)
  • WHO Collaborating Centre on Chemical Food Safety (8)
  • Pneumococci (7)
  • Respiratory infections (7)
  • Sustainability (7)
  • West Nile fever (7)
  • Mosquitos (6)
  • National Security (6)
  • Population screening programs in the Caribbean Netherlands (6)
  • Climate change and Health (5)
  • Food contact materials (5)
  • Healthy living environment (5)
  • Measles (5)
  • Nitrogen (5)
  • Respiratory syncytial virus (RSV) (5)
  • WHO Collaborating Centre for Infectious Disease Preparedness and IHR monitoring and evaluation (5)
  • Biobased economy (4)
  • Bisphenol A (BPA) (4)
  • Breast Cancer Screening Programme (4)
  • Dengue (4)
  • Endocrine disrupting chemicals (4)
  • Gonorrhoea (4)
  • HPV (4)
  • PIENTER Corona Study (4)
  • Population screening programmes (4)
  • Public Health Monitors (4)
  • Sustainable Development Goals (4)
  • Whooping cough (4)
  • Bird flu (avian influenza) (3)
  • Chromium (VI) and CARC (3)
  • Climate change (3)
  • DNA and public health (3)
  • Electromagnetic Fields (3)
  • Group A Strep infections (3)
  • Life Cycle Assessment (LCA) (3)
  • Lyme disease (3)
  • Malaria (3)
  • Meningococcal disease (3)
  • Physical Activity (3)
  • Tick-borne encephalitis (3)
  • UV index (3)
  • Wastewater research (3)
  • WHO Collaborating Centre for Immunotoxicology and Allergic Hypersensitivity; discontinued (3)
  • WHO Collaborating Centre for Nutrition (3)
  • Chikungunya (2)
  • Coronaviruses (2)
  • Ebola (2)
  • EU Reference Laboratory for Public Health on Vector-borne Viral Pathogens (EURL-PH-VBV) (2)
  • Legionella (Legionellosis) (2)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (2)
  • Livestock farming and health (2)
  • PFAS (2)
  • Probit functions (2)
  • Radiation and radioactivity (2)
  • Rubber tiles (2)
  • Salmonella (2)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (2)
  • Zika Virus (2)
  • Arboviruses (1)
  • Bestrijdingsmiddelen (1)
  • Chickenpox (1)
  • Contact (1)
  • Corona (1)
  • Doetinchem Cohort Study (1)
  • Dutch Food Composition Database (NEVO) (1)
  • Environmental and industrial safety (1)
  • Exploratory study into environmental pollution and health on Bonaire (1)
  • Fipronil in eggs (1)
  • Global Health Security (1)
  • Health promotion (1)
  • Healthy City (1)
  • Heel prick (1)
  • Hepatitis A (1)
  • Hepatitis B (1)
  • HPV - Humaan Papillomavirus (1)
  • Lifestyle interventions (1)
  • Marburg virus disease (1)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (1)
  • MERS (1)
  • NoroNet (1)
  • One Health (1)
  • Perinatal screening (1)
  • Pharmaceuticals in the environment (1)
  • Polio (1)
  • Rotavirus (1)
  • Scabies (1)
  • Shigellosis (1)
  • Shingles (1)
  • Synthetic biology (1)
  • WHO Collaborating Centre for Smallpox Vaccine (1)
  • WHO Collaborating Centre for the Family of International Classifications (FIC) (1)
  • WHO Collaborating Centre on Life Course and Health (1)

15 search results

You searched for these word(s): risk assessment
  • Infectious diseases

    https://www.rivm.nl/en/infectious-diseases

    … susceptible to infectious diseases and are at the greatest risk of serious complications or death. Vaccination reduces the risk of serious disease and complications and ensures that …

    Publication date: 04-29-2019
  • Hepatitis B

    https://www.rivm.nl/en/national-immunisation-programme/hepatitus-b

    … Children who have contracted hepatitis B are at particular risk of becoming chronic carriers of the virus. Children …

    Publication date: 09-20-2022
  • Updated immunisation recommendation for measles: early vaccination before travel

    https://www.rivm.nl/en/news/updated-immunisation-recommendation-for-measles-early-vaccination-before-travel

    … vaccination for children between 6 and 14 months who are at risk Children usually receive an MMR vaccination at the age … Children between 6 and 14 months who have a major risk of contracting a measles infection are eligible for …

    Publication date: 05-01-2019
  • Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination

    https://www.rivm.nl/en/news/article-in-lancet-infectious-diseases-on-rivm-research-into-maternal-pertussis-vaccination

    … whooping cough infections. They also have an increased risk of developing complications. When the mother is …

    Publication date: 04-04-2019
  • A pregnant woman can protect her baby against whooping cough with 22-week vaccination

    https://www.rivm.nl/en/news/pregnant-woman-protects-her-baby-against-whooping-cough-with-22-week-vaccination

    … All these studies showed that there is no increased risk of, for example, miscarriage or premature birth between …

    Publication date: 12-12-2019
  • Measles

    https://www.rivm.nl/en/measles

    … become very ill from measles?  Some people have a higher risk of severe symptoms:  Very young children. This … and have never had measles. These infants have an increased risk of severe illness and death. Older adults: the … Children with severely impaired immunity. They are at risk for a very serious and potentially fatal infection. …

    Publication date: 07-17-2013
  • Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

    https://www.rivm.nl/en/news/report-on-developments-of-national-immunisation-programme-national-immunisation-coverage

    … This vaccination is for children who are at greater risk of becoming seriously ill. A new study showed lower vaccine-effectiveness estimates for high-risk infants than expected. The ministry asked for a new …

    Publication date: 11-26-2020
  • RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

    https://www.rivm.nl/en/news/rivm-expands-hpv-vaccination-programme-girls-and-boys-protected-from-six-types-of-cancer-with

    … Protection from high-risk types  HPV is a very common, extremely infectious virus … types of HPV, including variants that present a high risk of cancer. HPV types 16 and 18 are the most dangerous. …

    Publication date: 01-31-2022
  • Vaccination rate increased, HPV even significantly

    https://www.rivm.nl/en/news/vaccination-rate-increased-hpv-even-significantly

    … chance of outbreaks Higher vaccination coverage reduces the risk of future outbreaks of diseases such as measles. It is …

    Publication date: 06-30-2020
  • National Immunisation Programme: slightly more cases in 2022, but fewer than before the COVID-19 pandemic

    https://www.rivm.nl/en/news/national-immunisation-programme-slightly-more-cases-in-2022-but-fewer-than-before-covid

    … Health Council of the Netherlands recommended inviting more risk groups for a flu vaccination, including pregnant women. …

    Publication date: 11-23-2023
  • Growth of digital healthcare stabilised in 2023

    https://www.rivm.nl/en/news/growth-of-digital-healthcare-stabilised-in-2023

    … RIVM looked into how people with an increased/elevated risk of type 2 diabetes (prediabetics) and people whose …

    Publication date: 04-11-2024
  • Significantly fewer babies in Dutch ICUs thanks to injection against RSV

    https://www.rivm.nl/en/news/significantly-fewer-babies-in-dutch-icus-thanks-to-injection-against-rsv

    … as early as possible. Very young children have the highest risk of ending up in hospital for RSV. The virus is …

    Publication date: 02-16-2026
  • Mumps

    https://www.rivm.nl/en/mumps

    … generally make a full recovery. Some people have a higher risk of becoming ill from mumps. This applies to babies …

    Publication date: 02-14-2024
  • SocioVax: social science research on vaccination

    https://www.rivm.nl/en/behavioural-science/sociovax

    … Thinking and feeling , such as: -  the perceived disease risk -  vaccine confidence (e.g. perceived benefits, safety …

    Publication date: 05-30-2024
  • National Immunisation Programme: new decline in number of reported cases of disease in 2021

    https://www.rivm.nl/en/news/national-immunisation-programme-new-decline-in-number-of-reported-cases-of-disease-in-2021

    … all young babies against the rotavirus and inviting more risk groups to receive the flu vaccine, including pregnant …

    Publication date: 11-17-2022

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon